CALCITONIN-SALMON (calcitonin salmon) by Pfizer is calcitonin-salmon is a calcitonin receptor agonist. Approved for postmenopausal osteoporosis in women greater than 5 years postmenopause, osteoporosis, osteoporosis. First approved in 2009.
Drug data last refreshed 23h ago
Calcitonin-salmon is a calcitonin receptor agonist. Calcitonin-salmon acts primarily on bone, but direct renal effects and actions on the gastrointestinal tract are also recognized. Calcitonin-salmon appears to have actions essentially identical to calcitonins of mammalian origin, but its potency…
Calcitonin
Worked on CALCITONIN-SALMON at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.